What is Captivate Bio?
Captivate Bio operates at the intersection of scientific innovation and industrial manufacturing, specializing in the development and commercialization of cGMP cell culture media, matrices, and cryopreservation tools. The company distinguishes itself through a transparent, collaborative approach to scientific challenges, prioritizing the empowerment of researchers and the seamless delivery of critical laboratory technologies.
Beyond its core product offerings, the firm has emerged as a key player in strengthening domestic manufacturing infrastructure. By focusing on US-based production, Captivate Bio addresses the supply chain vulnerabilities highlighted by recent global health crises, ensuring that therapeutic organizations have consistent, affordable access to the essential materials required for clinical research and cell therapy development.
How much funding has Captivate Bio raised?
Captivate Bio has raised a total of $154K across 1 funding round:
Debt
$154K
Debt (2024): $154K with participation from Rockland Trust
Key Investors in Captivate Bio
Rockland Trust
A full-service commercial bank providing financial solutions and capital support to businesses across various sectors, including the life sciences industry.
What's next for Captivate Bio?
With the recent influx of capital, Captivate Bio is poised to execute an aggressive expansion strategy centered on operational excellence and market penetration. The company intends to further optimize its supply chain logistics, ensuring that its portfolio of cell processing tools reaches a broader network of therapeutic and healthcare organizations. Furthermore, the firm is expected to deepen its collaborative partnerships, fostering a more integrated ecosystem for scientific discovery.
As the company transitions into this next phase of growth, the focus will remain on scaling its manufacturing footprint while maintaining the rigorous quality standards required for clinical-grade applications. By prioritizing transparency and scientific integrity, Captivate Bio is set to play a pivotal role in the future of regenerative medicine and the broader biotechnology sector.
